Management of Inflammatory Bowel Disease
V. ALIN BOTOMAN, GREGORY F. BONNER, DANIELA A. BOTOMAN
Advances in the management of inflammatory bowel disease include the newer 5-aminosalicylic acid compounds and corticosteroid analogs with fewer side effects.